AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Current therapy of advanced cancers is based on several modalities including radiotherapy,
cytotoxic chemotherapy, molecularly targeted inhibitors and antibodies targeting immune …

ESC Guidelines e341 (1) the specific situation of the patient. In this respect, it is specified
that, unless otherwise provided for by national regulations, offlabel use of medication should …

Importance Radiotherapy accelerates coronary heart disease (CHD), but the dose to critical
cardiac substructures has not been systematically studied in lung cancer. Objective To …

Abstract Aim Cardiotoxicity (CTox) is a major side effect of cancer therapies, but uniform
diagnostic criteria to guide clinical and research practices are lacking. Methods and results …

Background: Radiotherapy-associated cardiac toxicity studies in patients with locally
advanced non–small cell lung cancer (NSCLC) have been limited by small sample size and …

Coronary artery disease (CAD) is an important contributor to the cardiovascular burden in
cancer survivors. This review identifies features that could help guide decisions about the …

SciELO - Brasil - Diretriz Brasileira de Cardio-oncologia – 2020 Diretriz Brasileira de Cardio-oncologia
– 2020 Acessibilidade / Reportar erro Brasil Lista alfabética de periódicos Lista temática de …

Abstract Background/Aims While overall rates of colorectal cancer (CRC) have declined in
individuals aged above 50 years of age, this decline has not been seen in younger …

Aims Current guidelines recommend sacubitril/valsartan for patients with heart failure and
reduced left ventricular ejection fraction (LVEF), but there is lack of evidence of its efficacy …